LCAM 2022

Every year, the world commemorates Lung Cancer Awareness Month in November to increase awareness on the disease. Lung cancer remains the most diagnosed cancer across the globe. According to the Singapore Cancer Registry Report 2019, lung cancer is the 3rd most commonly diagnosed cancer among men and women in Singapore, with more than 60% of lung cancer diagnosed at Stage IV between 2015 and 2019. It has the highest cancer mortality rate among Singaporean men and the third highest cancer mortality rate among Singaporean women. Specifically, more non-smokers are getting lung cancer in the last decade and majority of females with lung cancer have not smoked before. Lung cancer typically has no symptoms until the advanced stages, and is hence often not detected until late.

Low-dose computed tomography (LDCT) screening of lung cancer is intensively being studied and implemented internationally as means to detect lung cancer early. In conjunction with Lung Cancer Awareness Month 2022, the first local lung cancer screening study, SingapOre Lung cancer Screening Through Integrating CT with other biomarkErs (SOLSTICE) will be launched on SingHealth Outram Campus. The study aims to recruit both smoking and at-risk non-smoking participants.

Refer to study recruitment poster below.

“An ounce of prevention is worth a pound of cure."

- Benjamin Franklin

If you have questions pertaining the study, please email to lung.cancer.screening@singhealth.com.sg.